A comprehensive view of Pfizer Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Beauty & Personal Care Market Intelligence Service.
Healthcare professionals rank AbbVie as top player in immunology, despite competition from Pfizer and J&J, according to ZoomRx analysis; AbbVie scored highest in innovation and patient centricity, while Pfizer and J&J ranked second and third respectively
Published:
April 19, 2024
by FiercePharma
|
Pfizer Applies for Patent on Anti-Proliferative Agents for Treating Pah
Published:
April 19, 2024
by Pharmaceutical Patent News
|
Pfizer Applies for Patent on Imidazo[4,5-C]Pyridine Derivatives as Toll-Like Receptor Agonsits
Published:
April 18, 2024
by Pharmaceutical Patent News
|
Pfizer Applies for Patent on Recombinant Expression of Klebsiella Pneumoniae O-Antigens in Escherichia Coli
Published:
April 17, 2024
by Biotechnology Patent News
|
US Patent Issued to Pfizer, The Regents of the University of California on April 16 for "Anti-CXCR5 antibodies and compositions and uses thereof" (California Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
Ask us about our Beauty & Personal Care market view